The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Leber Laura since 2015.
The trader's CIK number is 1649191.
At the time of the last reporting, Leber Laura was the Chief Communication Officer of Genomic Health Inc. (stock ticker symbol GHDX).
Also see all insider trading activities at Genomic Health Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | GHDX | 0 | $0 | 37,567 | $2,962,123 | 33,750 | $666,824 |
| 2018 | GHDX | 0 | $0 | 3,374 | $111,804 | 0 | $0 |
| 2017 | GHDX | 0 | $0 | 24,072 | $796,941 | 21,000 | $414,209 |
| 2016 | GHDX | 0 | $0 | 7,068 | $224,267 | 3,600 | $62,676 |
| 2015 | GHDX | 0 | $0 | 4,200 | $123,202 | 4,200 | $42,630 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-10-17 | GHDX | Sale | 13,183 | 70.94 | 935,228 |
| 2019-10-17 | GHDX | Option Ex | 13,183 | 22.98 | 302,945 |
| 2019-02-20 | GHDX | Option Ex | 18,750 | 17.18 | 322,125 |
| 2019-02-21 | GHDX | Option Ex | 1,817 | 22.98 | 41,754 |
| 2019-02-20 | GHDX | Sale | 18,750 | 83.12 | 1,558,462 |
| 2019-02-21 | GHDX | Sale | 5,634 | 83.14 | 468,433 |
| 2018-02-20 | GHDX | Sale | 3,374 | 33.14 | 111,804 |
| 2017-12-15 | GHDX | Sale | 9,000 | 35.00 | 315,000 |
| 2017-12-14 | GHDX | Option Ex | 12,000 | 21.52 | 258,240 |
| 2017-12-15 | GHDX | Option Ex | 9,000 | 17.33 | 155,969 |
| 2017-12-14 | GHDX | Sale | 12,000 | 32.00 | 384,000 |
| 2017-03-20 | GHDX | Sale | 3,072 | 31.88 | 97,941 |
| 2016-11-21 | GHDX | Option Ex | 3,600 | 17.41 | 62,676 |
| 2016-11-21 | GHDX | Sale | 7,068 | 31.73 | 224,267 |
| 2015-12-07 | GHDX | Option Ex | 4,200 | 10.15 | 42,630 |
| 2015-12-07 | GHDX | Sale | 4,200 | 29.33 | 123,202 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Leber Laura (Chief Communication Officer of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.